Study Title
A Randomized Phase III Trial of Platinum Chemotherapy plus Paclitaxel with Bevacizumab and Atezolizumab versus Platinum Chemotherapy plus Paclitaxel and Bevacizumab in Metastatic (stage IVB), Persistent, or Recurrent Carcinoma of the Cervix. (GOG-3030)
Purpose
To determine whether the addition of atezolizumab to chemotherapy and bevacizumab improves overall survival compared to chemotherapy plus bevacizumab in patients with metastatic persistent or recurrent carcinoma of the cervix
Eligibility
Study Process
Trial Details
Investigator:
Destin Black, M.D.
IRB:
WIRB
IRB Number:
Trial Type:
NA
Sponsor:
GOG
Contact Information:
Gynecologic Oncology Associates
(318) 212-8727
http://www.wkgynonc.com